TRex Bio(NASDAQ) TRXB

Market Cap$373.26MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2026)-3%
5 YearN/A
1 YearN/A
1 MonthN/A
$13.60
-3.07%
-0.43Today
TRex Bio last closing stock price
MetricPriceDate
Last closeUSD 13.602026-10-13
TRex Bio stock price return by period
PeriodPrice returnPrice at period startPeriod start date
Since inception-2.86%USD 14.002026-10-09

TRex Bio Financials at a Glance

Market Cap

$373.26MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$13.60

Volume

126,152.583

Open

$13.95

Previous Close

$13.60

Daily Range

$13.47 - $14.08

52-Week Range

$13.47 - $15.50

Estimated Earnings Date

N/A

TRXB News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About TRex Bio

TRex Bio Inc. is a biotechnology company focused on developing immunotherapies for autoimmune and inflammatory diseases. The company aims to create breakthrough medicines by studying the regulation of tissue inflammation. Founded in 2018 and headquartered in South San Francisco, TRex Bio is positioned in the healthcare sector, specifically within the pharmaceuticals industry.

Products and Services
  • Immunotherapies targeting autoimmune diseases
  • Innovative treatments for inflammatory conditions
  • Research and development in tissue inflammation regulation
Growth Outlook
  • Strong focus on breakthrough medicines enhances market potential
  • Expanding research initiatives may lead to new product lines
  • Strategic partnerships could accelerate development timelines
Financial Highlights
  • Market capitalization of $116.62 million indicates growth potential
  • Recent stock price range between $13.5 and $15.5 shows stability
  • Average trading volume of 1.25 million shares reflects investor interest
TRex Bio Inc. is dedicated to addressing significant healthcare challenges through innovative therapies. The company's commitment to research and development positions it well for future growth in the competitive biotechnology landscape. With a solid market capitalization and a stable stock price range, TRex Bio presents an intriguing opportunity for investors interested in the pharmaceutical sector. The focus on immunotherapies and inflammation regulation underscores the potential for impactful advancements in treatment options.
AI Generated • Oct 11, 2026

Industry

Biotechnology

Sector

Health Care

CEO

Marion Johnston Erwin, Jr.

Website

www.trex.bio

Headquarters

South San Francisco, CA 94080, US

TRXB Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

$373.26MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

27.45M

Volume

126.15K

Avg. Volume

393.42K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

TRex Bio Performance Analysis

TRex Bio annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20242024-12-31USD 39,108,000N/A
20252025-12-31USD 0N/A
TRex Bio annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20242024-12-31USD -0.32N/A
20252025-12-31USD -1.27291.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

$373.26MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,803.85-0.00%
^DJIDJI
$51,687.96-0.00%
^IXICNASDAQ
$27,201.84-0.00%
BTCBitcoin
$83,069.00+0.01%

Trending Stocks

Symbol / CompanyPricePrice Chg
VTEBVanguard Municipal Bond Funds - Vanguard Tax-Exempt Bond ETF
$47.65+0.57%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$37.42+0.62%
KORUDirexion Shares ETF Trust - Direxion Daily Msci South Korea Bull 3x Shares
$14.72-6.48%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$127.57-0.65%

Questions About TRXB

What is the current price of TRex Bio?

TRex Bio is trading at $13.60 per share.

What is the 52-week range for TRex Bio?

Over the past 52 weeks, TRex Bio has traded between $13.47 and $15.50.

How much debt does TRex Bio have?

As of the most recent reporting period, TRex Bio reported total debt of $717.00K.

How much cash does TRex Bio have on hand?

TRex Bio reported $15.19M in cash and cash equivalents in its most recent financial results.

What is TRex Bio’s dividend yield?

TRex Bio does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services